Clinical trial services provider Ergomed has announced the establishment of a Rare Disease Innovation Center, a consortium dedicated to optimizing rare disease trials and leveraging real-world evidence (RWE).

The consortium will help sponsors and sites improve their trial designs, protocols, study feasibility assessments and performance metrics. Consortium members, including Trial Bee, mdgroup, THREAD, ClinOne, Medidata, PatientWing and Rare Patient Voice, will also help sponsors apply RWE in synthetic control arms, biomarker development, endpoint selection, patient selection, registry review and other aspects of rare disease trials.

It also will support patient identification and retention efforts by helping sponsors adopt new technology, including decentralized trial approaches.